IPO Trending
GAUDIUMIVFEQ / NSE, BSEListed

Gaudium IVF And Women Health Limited

Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.

₹75 - ₹797.27x sub
Listed Price83.00
Listing Gain+5.06%
TimelineBookbuilding IPO
Open20 Feb 2026
Close24 Feb 2026
Allotment25 Feb 2026
Listing27 Feb 2026

Quota Reservation Portions

AnchorPortion: 62,65,860 shares
30%
QIBPortion: 41,77,240 shares
20%
HNIPortion: 31,32,930 shares
15%
RetailPortion: 73,10,170 shares
35%

Minimum Application Bracket Matrix

Retail1 lots / 189 shares
₹14,931
sHNI14 lots / 2,646 shares
₹2,09,034
bHNI67 lots / 12,663 shares
₹10,00,377

About the Company

Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.

Company Promoters

Dr. Manika KhannaDr. Peeyush KhannaVishad Khanna